These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 16273366

  • 41. Are all aromatase inhibitors the same? A review of the current evidence.
    Jänicke F.
    Breast; 2004 Dec; 13 Suppl 1():S10-8. PubMed ID: 15585378
    [Abstract] [Full Text] [Related]

  • 42. The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis.
    Punglia RS, Kuntz KM, Winer EP, Weeks JC, Burstein HJ.
    Cancer; 2006 Jun 15; 106(12):2576-82. PubMed ID: 16703595
    [Abstract] [Full Text] [Related]

  • 43. Extended adjuvant endocrine therapy of early breast cancer.
    Chowdhury S, Ellis P.
    Curr Med Res Opin; 2005 Dec 15; 21(12):1985-95. PubMed ID: 16368050
    [Abstract] [Full Text] [Related]

  • 44. Aromatase inhibitors for treatment of postmenopausal patients with breast cancer.
    Tamaki Y, Miyoshi Y, Kim SJ, Tanji Y, Taguchi T, Noguchi S.
    Expert Rev Anticancer Ther; 2003 Apr 15; 3(2):193-201. PubMed ID: 12722879
    [Abstract] [Full Text] [Related]

  • 45. Reducing early recurrence with adjuvant aromatase inhibitors: what is the evidence?
    Dixon JM.
    Breast; 2008 Aug 15; 17(4):353-60. PubMed ID: 18490163
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Quality of life of postmenopausal women in the ATAC ("Arimidex", tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer.
    Cella D, Fallowfield L, Barker P, Cuzick J, Locker G, Howell A, ATAC Trialistsa9 Group.
    Breast Cancer Res Treat; 2006 Dec 15; 100(3):273-84. PubMed ID: 16944295
    [Abstract] [Full Text] [Related]

  • 48. Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial.
    Fallowfield L, Cella D, Cuzick J, Francis S, Locker G, Howell A.
    J Clin Oncol; 2004 Nov 01; 22(21):4261-71. PubMed ID: 15514369
    [Abstract] [Full Text] [Related]

  • 49. [Adjuvant treatment of breast cancer by concomitant hormonotherapy and radiotherapy: state of the art].
    Azria D, Lemanski C, Zouhair A, Gutowski M, Belkacémi Y, Dubois JB, Romieu G, Ozsahin M.
    Cancer Radiother; 2004 Jun 01; 8(3):188-96. PubMed ID: 15217586
    [Abstract] [Full Text] [Related]

  • 50. Anastrozole for breast cancer: recent advances and ongoing challenges.
    Buzdar AU.
    Expert Rev Anticancer Ther; 2006 Jun 01; 6(6):839-48. PubMed ID: 16761927
    [Abstract] [Full Text] [Related]

  • 51. New developments in the treatment of postmenopausal breast cancer.
    Howell A.
    Trends Endocrinol Metab; 2005 Nov 01; 16(9):420-8. PubMed ID: 16213745
    [Abstract] [Full Text] [Related]

  • 52. Adjuvant endocrine therapy for early breast cancer.
    Andreetta C, Smith I.
    Cancer Lett; 2007 Jun 18; 251(1):17-27. PubMed ID: 17150303
    [Abstract] [Full Text] [Related]

  • 53. Reducing the risk of distant metastases in breast cancer patients: role of aromatase inhibitors.
    Del Mastro L, Clavarezza M, Venturini M.
    Cancer Treat Rev; 2007 Dec 18; 33(8):681-7. PubMed ID: 17850976
    [Abstract] [Full Text] [Related]

  • 54. Adjuvant aromatase inhibitor therapy: outcomes and safety.
    Janni W, Hepp P.
    Cancer Treat Rev; 2010 May 18; 36(3):249-61. PubMed ID: 20133065
    [Abstract] [Full Text] [Related]

  • 55. Adjuvant aromatase inhibitors following tamoxifen for early-stage breast cancer in postmenopausal women: what do we really know?
    Chung CT, Carlson RW.
    Clin Breast Cancer; 2004 Sep 18; 5 Suppl 1():S18-23. PubMed ID: 15347435
    [Abstract] [Full Text] [Related]

  • 56. Preliminary data from ongoing adjuvant aromatase inhibitor trials.
    Goss PE.
    Clin Cancer Res; 2001 Dec 18; 7(12 Suppl):4397s-4401s; discussion 4411s-4412s. PubMed ID: 11916231
    [Abstract] [Full Text] [Related]

  • 57. Adjuvant use of aromatase inhibitors in postmenopausal women with breast cancer.
    Michaud LB.
    Am J Health Syst Pharm; 2005 Feb 01; 62(3):266-73. PubMed ID: 15719584
    [Abstract] [Full Text] [Related]

  • 58. Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer.
    Buzdar AU, Coombes RC, Goss PE, Winer EP.
    Cancer; 2008 Feb 01; 112(3 Suppl):700-709. PubMed ID: 18072256
    [Abstract] [Full Text] [Related]

  • 59. Adjuvant therapy of breast cancer.
    Kaklamani VG, Gradishar WJ.
    Cancer Invest; 2005 Feb 01; 23(6):548-60. PubMed ID: 16203663
    [Abstract] [Full Text] [Related]

  • 60. Selective oestrogen receptor modulators, aromatase inhibitors and the female breast.
    Howell A.
    Curr Opin Obstet Gynecol; 2005 Aug 01; 17(4):429-34. PubMed ID: 15976552
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.